Live Q&A: COVID-19: Setting the Stage for Improved Outcomes with Targeted Therapies

CMEO Webcast

Premiere Date: Thursday, March 10, 2022

This activity will offer CE credit for:

  1. Medicine (accme)
  2. Nursing (ANCC)
  3. Pharmacy (acpe)
  4. PA (aapa)

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Friday, March 10, 2023
Note: Credit Is No Longer Available


David Alain Wohl, MD
David Alain Wohl, MD (Moderator)
Professor of Medicine
Institute of Global Health and Infectious Diseases
Site Leader, Global Infectious Diseases Clinical Trials Unit, Chapel Hill Site
The University of North Carolina (UNC) at Chapel Hill School of Medicine
Chapel Hill, NC

Aima A. Ahonkhai, MD, MPH
Aima A. Ahonkhai, MD, MPH 
Assistant Professor of Medicine
Vanderbilt University Medical Center
Division of Infectious Diseases
Vanderbilt Institute for Global Health
Nashville, TN

Onyema Ogbuagu, MBBCh, FACP, FIDSA
Onyema Ogbuagu, MBBCh, FACP, FIDSA 
Associate Professor of Medicine (AIDS)
Director, Clinical Trials Program, Yale AIDS Program
Section of Infectious Diseases
Yale School of Medicine
New Haven, CT

Pratish C. Patel, PharmD, BCIDP, AAHIVP
Pratish C. Patel, PharmD, BCIDP, AAHIVP 
Program Director, Pharmacy
Vanderbilt University Medical Center
Nashville, TN

Statement of Need

The COVID-19 pandemic has challenged the world like no other health-related crisis in modern history, and although vaccines have been shown to stop transmission, far too many people remain unvaccinated; variants may still put unvaccinated and vaccinated individuals at risk for infection. A number of targeted therapies that can stop COVID-19 and be given as simple-to-administer regimens are vital to recovery. There is currently an active and robust field of research surrounding the search for such therapies, but they will only fulfill their potential if used early in the disease course.

This live question and answer session is your opportunity to ask questions based on the CME Outfitters Live and OnDemand program on improving clinician knowledge of the short-term and long-term health consequences of COVID-19 and identifying patients who would benefit from timely interventions that can decrease mortality and morbidity. To view the full activity ahead of this live Q&A, click here.

Learning Objectives

At the end of this CME/CE activity, participants should be able to:

  • Characterize the short-term and long-term disease burden of COVID-19.
  • Evaluate patients with COVID-19 to make appropriate treatment recommendations to optimize quality of care and patient outcomes.
  • Identify best practices to support the utilization of currently approved or authorized agents, and emerging agents for the treatment of COVID-19.

Financial Support

Supported by an educational grant from Pfizer Inc. and Merck Sharp & Dohme Corp.

Target Audience

Internists, emergency/urgent care clinicians, primary care physicians, PAs, nurse practitioners, nurses, and pharmacists

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME):
CME Outfitters, LLC, designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC):
This activity is designated for 0.5 contact hours.

Note to Nurse Practitioners:
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.

California Residents:
This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.

Pharmacists (ACPE):
This knowledge-based activity is approved for 0.5 contact hours (0.05 CEUs) of continuing pharmacy credit (JA0007185-0000-22-003-L01-P).

AAPA CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Wohl reports that he receives research support and grants from Gilead Sciences, Inc.; Merck & Co., Inc.; and ViiV Healthcare. He reports that he is on the advisory committee for Gilead Sciences, Inc.; Janssen Pharmaceutical, Inc.; Merck & Co., Inc. and ViiV Healthcare.

Dr. Ahonkhai reports she receives research support from National Institutes of Health (NIH). She is a consultant for the CDC Foundation. She serves on the advisory board for ViiV Healthcare and Gilead Sciences, Inc. (specific to HIV treatment).

Dr. Ogbuagu reports that he receives grants from Gilead Sciences, Inc. He reports that he is on the speakers bureau for Gilead Sciences, Inc. He reports that he is a consultant for ViiV Healthcare.

Dr. Patel has no disclosures to report.

Michael Franks, APRN, AGACNP-BC, FNP-BC (peer reviewer) has no disclosures to report.

Kathleen Blake, PhD (planning committee) has no disclosures to report.

Janan Sarwar, PharmD (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

This document was last modified on: